Spaulding Clinical Announces Partnership with clinicalRSVP

March 12, 2012 – West Bend, Wisconsin, USA – Spaulding Clinical Research, LLC, a US-based leading-edge clinical pharmacology unit, cardiac core lab and medical device manufacturer, announced it be will be partnering with clinicalRSVP (clinical Research Subject Verification Program), the leading provider of participant registry services. This partnership illustrates Spaulding Clinical’s ongoing commitment to subject safety and data integrity.

Spaulding Clinical will join participating clinical sites that utilize clinicalRSVP to check subject eligibility requirements before dosing commences. Spaulding Clinical is the first site in the Midwest to join clinicalRSVP’s network, which includes sites located along both coasts. The addition of Spaulding Clinical expands the reach of the clinicalRSVP site network, and greatly strengthens the relevance of the network for participating sites.

clinicalRSVP was chosen by Spaulding Clinical as its preferred provider of dual enrollment protection services due to clinicalRSVP’s expansive network, proven track record, ease of operational implementation, and regulatory compliance. clinicalRSVP has years of experience in providing registry services; the company has developed a network of sites that currently includes more than 25 percent of all Phase I beds in North America.

“Dual enrollment is becoming an incredibly hot topic in the clinical pharmacology circuit as sponsors are becoming very keen to ensure subjects are only in their studies,” commented Daniel Selness, general manager & senior vice president of operations at Spaulding Clinical. “Spaulding is pleased to be able to provide this added measure of diligence for our study sponsors.”

“The addition of Spaulding Clinical represents a terrific advancement for clinicalRSVP and for those who sponsor and conduct Phase I clinical trials across North America,” said Darran Boyer, president of clinicalRSVP. “We are pleased that the network now spans from coast to coast, including the Midwest and into Canada. We see the continued growth of this Phase I network as a positive sign of things to come.”

clinicalRSVP (idi.clinicalRSVP.com) is the North American network that prevents research volunteers from enrolling in multiple research studies concurrently. This blinded cooperative registry allows investigators to confidentially and securely verify subject eligibility requirements prior to subject enrollment in clinical trials, resulting in advances to clinical research data integrity and participant safety.

Spaulding Clinical Research, LLC (www.spauldingclinical.com) provides clinical pharmacology and cardiac core lab clinical research services, and is a medical device manufacturer. Spaulding Clinical operates a 105-bed clinical pharmacology unit with 96 beds of telemetry in West Bend, Wisconsin, USA. As a Phase I-IV core ECG laboratory provider, Spaulding Clinical offers the complete suite of equipment provisioning and electrocardiograph over-reading services.

 

clinicalRSVP Media Contact
Lisa Rehberger
Director, Business Development
Tel:  (954) 918-9365
Email:  [email protected]

Spaulding Clinical Media Contact
Kathy Forde
Sr. Director of Marketing
Tel:  (414) 303-1912
Email:  [email protected]